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molecular mechanism(s) of tumor cell migration, invasion and establishment of colonies (13) . In this regard, experimental animal models may provide valuable insight into the molecular mechanism(s) by which inflammation and pulmonary colonization of tumor cells may be linked and facilitate the identification of drug targets for the development of novel anti-metastatic therapies.
Uteroglobin (UG) 3 (14) , also known as Clara cell 10kDa (CC10) protein (15) , is a steroidinducible secreted protein with potent antiinflammatory properties. It is constitutively expressed in the lungs of all mammals and targeted disruption of the UG gene in mice (16) increases susceptibility to pulmonary inflammation (17) . Moreover, we (18) and others (19) have previously demonstrated that overexpression of UG in cancer cells reverses their transformed phenotype and neoplastic potential. We also demonstrated that UG-knockout (UG-KO) mice (16) are highly susceptible to lung tumorigenesis by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a carcinogen in cigarette smoke (20) . Previously, we reported that the UG gene is constitutively expressed at a high level in the lung epithelia (21) . However, UG expression in both malignant lung tumors originating from lung epithelia as well as in the cell lines derived from these tumors is either drastically suppressed or totally undetectable (22, 23) . Further, we demonstrated that UG prevents migration and ECM-invasion of cancer cells in vitro (24) .
Pathogenesis of many diseases mediated via aging, infectious agents, inflammation or genetic damage often leads to changes in gene expression (reviewed in 25) . Recent reports indicate a link between inflammation and cancer metastasis (10, 12) . Moreover, emerging evidence suggests that pre-existing inflammation in the tumor microenvironment stimulates angiogenesis, promotes cancer cell survival and metastasis (4, 12) . Molecular mechanism by which inflammation is linked to metastasis is beginning to emerge. The receptor for advanced glycation end products (RAGE) is a multi-ligand, pattern-recognizing receptor of the immunoglobulin superfamily of proteins (26, 27) . RAGE-signaling has been reported to activate NF-kB, MAP kinases and Src kinases leading to inflammation and cell proliferation. Among its various ligands, this receptor also interacts with the S100 family of Ca ++ -binding proteins (28) including, S100A8 (also known as MRP8, Calgranulin A) (29) and S100A9 (also called MRP14, Calgranulin B) (27) and play critical roles in transducing inflammatory response (30, 31) .
UG-knockout (UG-KO) mice that are highly susceptible to developing pulmonary inflammation and B16F10 melanoma cells, which preferentially metastasize to the lungs (6, 9) , provide the components of a model system that can be utilized to explore whether: (i) lack of UG promotes metastasis and if so, (ii) what might be the mechanism(s) that regulate cancer cell migration from a peripheral site of injection to a distant organ (e.g. Lung) and finally establish as metastatic tumors. Here we report that high level expression of S100A8 and S100A9 in the lungs of the UG-KO mice and the existence of a concentration gradient of these proteins from the peripheral circulation to the lungs provide a road map for the B16F10 cells migrate to the lungs. We also discovered for the first time that B16F10 cells express RAGE. Thus, S100A8 and S100A9 provide the homing signal for RAGE-expressing B16F10 cells to migrate to this organ, which contains the highest concentration of these proteins. Most importantly, treatment of B16F10 cells with a blocking antibody to RAGE dramatically suppresses S100A8/S100A9-mediated chemotactic migration suggesting that the migration of these cells is RAGE-specific. Taken together, our results show that lack of an endogenous anti-inflammatory protein such as UG may lead to increased migration and colonization of melanoma cells in the lungs identifying RAGE as a critical element in this process and a potential target for anti-metastatic drug development.
EXPERIMENTAL PROCEDURES
Animals-UG-KO mice were generated by targeted disruption of the UG-gene in ES cells as described previously (18) . Both UG-KO mice and their WT littermates were maintained under germfree conditions and all experiments were performed according to a protocol approved by the institutional Animal Care and Use Committee.
Cell
Culture-B16-F10 cells were purchased from American Type Culture Collection and were cultured in DMEM containing 10% fetal bovine serum.
Tumor metastasis-A suspension of 2X10 5 B16F10 cells in PBS was injected in the dorsal tail vain of UG-KO mice and their WT littermates. After 21days of B16F10 cell injection, the animals were euthanized and the lungs perfused with PBS. The lung tissues were then fixed in 4% paraformaldehyde. The number of tumor colonies formed were counted and recorded.
Histological analysis-The animals were sacrificed 21 days following injection of B16F10 cells into the dorsal tail vein. The lungs were then perfused with PBS and fixed by intratracheal administration of 4.0% neutral buffered formalin. After fixation, the tissues were embedded in paraffin and sectioned. Lung sections were stained with hematoxilin and eosin (American Histolab, Inc., Gaithersburg, MD). The stained tissue sections were examined using an Axioskop2 plus Microscope (Carl Zeiss Microimaging, Inc.) and digital photomicrographs were recorded.
Generation of conditioned medium and migration assays-Perfused lungs from the UG-KO mice as well as those of their WT littermates were sectioned (2-mm 2 ) using sterile instruments and cultured in DMEM for 90 minutes as described previously (32) . The organ culture media were centrifuged and the supernatants were stored at -80°C until used as chemoattractant in the migration assay.
Suppression of RAGE expression by siRNA-To suppress the RAGE expression, B16F10 cells were transfected with RAGE-specific siRNA (Ambion) as described earlier (33) . As a negative control, cells were transfected with a scrambled siRNA (Ambion). SiPORT lipid Transfection agent (Ambion) was used and transfection was performed following the manufacturer's protocol. Total proteins were prepared from the cells 72 h after transfection and expression of RAGE was checked by western blotting to confirm RAGE siRNA mediated down regulation. The siRNAtransfected B16F10 cells were used after 72 hours for in-vitro invasion assay as well as injected to UG-KO mouse tail vein.
In vitro migration and invasion assays-
The 6-well chambers with polycarbonate filters, with a pore size of 8.0 µm (BD Biosciences) were used to perform the migration assays. The lower compartment was filled with 2ml of media containing various chemoattractants (i.e. conditioned media from culturing WT and UG-KO lung sections; DMEM containing 0.1% bovine serum albumin (BSA) with either recombinant S100A8 (100pg/ml), S100A9 (1ng/ml) (Abnova, Taiwan) or a combination of S100A8 and S100A9 (32) . DMEM containing 0.1% bovine serum albumin (BSA) alone served as a control. B16F10 cells (1x10 5 ) were re-suspended in 2ml of DMEM, and placed in the upper chamber. Cell migration through the porous filter was allowed to take place for 12 hr in a humidified atmosphere of 5% CO 2 at 37°C. The upper surface of the filter was scraped with moist cotton swabs to remove non-migrated cells and then the cells attached to the lower surface of the filters (i.e. the migrated cells) were stained with HEMA3 (Fisher Scientific) according to the manufacturer's protocol. The migrated cells were photographed and counted in at least twelve different fields (magnification, X200); the results are expressed as the mean of at least 3 determinations +SD.
In some experiments, B16F10 cells (1x10 5 /ml) were pretreated with a blocking goat antibody to RAGE (R&D) at a concentration of 10µg/ml for 1hr in DMEM containing 0.1% BSA. Cells were washed three times to remove any unbound antibody before using these cells for the migration assay. Similarly, B16F10 cells were pretreated with a non-specific goat IgG and used as a negative control. For in vitro invasion assay, similar steps were followed as for in vitro migration assay, but instead of chambers with only polycarbonate filters, chambers with Matrigel coated filters (BD Biosciences) were used.
Stimulation of MMP expressions in
B16F10 cells by S100A8/A9-B16-F10 cells were cultured in DMEM medium containing 10% fetal bovine serum with a seeding density 10 6 per T75 flask. The cells were treated with various concentrations of S100A8 (0.2, 1.0 or 2.0 µg/ml) or S100A9 (0.2, 1.0 or 2.0 µg/ml) alone or in combination (0.2 or 1.0 µg/ml of each) for 24 hours. B16-F10 cells without any treatment were kept as control. RNA and proteins were prepared from the treated as well as untreated control B16F10 cells and were used in real time RT PCR and Western blot analyses, respectively.
RNA isolation and Quantitative
Real-time PCR-Total RNA was isolated using QIAGEN RNeasy Mini Kit and treated with DNase (DNase I, 30 U/µg total RNA). Reverse transcribed and quantitative RT-PCR analysis was performed as described previously (33) . The cDNA equivalent of 10 ng total RNA was used as the template. The PCR primers used for real-time RT-PCR are shown in Supplemental Table S1 . The  data normalized to ß-actin or GAPDH, were analyzed using ABI Prism Software version 1.01 (Applied Biosystems) and presented as fold change compared with controls. Quantitation was performed using at least three independent total RNA samples for each treatment groups and the results are expressed as the mean ± S.D.
Western Blot Analyses-Total protein (30 µg) from each sample was resolved by electrophoresis using 4-12% NuPAGE Bis-Tris gels (Invitrogen) under reducing conditions and electrotransferred to nitrocellulose membrane (Invitrogen). Immunoblot analysis was performed using S100A8, S100A9 (1:1000, R&D Systems), RAGE (1:750, Abcam), ß-Actin (1:5000, US Biological), Albumin (1:1000, Upstate Biotechnology), MMP2 (1:1000, Abcam), MMP9 (1:1000 Millipore), MMP14 (1:1000, Abcam), Furin (1:500 Santa Cruz Biotech) antibodies. Horseradish peroxidase-conjugated anti-rabbit IgGs, anti-goat IgGs and anti-mouse IgGs (Santa Cruz Biotechnology) were used as the second antibodies. Chemiluminescent detection was performed by using Supersignal west pico luminol/enhancer solution (Thermo scientific) according to the manufacturer's protocol.
Confocal Microscopy-The B16F10 cells were incubated at 37°C in an atmosphere of 5% of CO2 and 95% air for 24 h. Cells were washed three times with PBS, pH 7.6 and incubated in 4.0% formaldehyde solution for 15 min for fixation. The fixed B16F10 cells and the lung tissue sections of B16F10-injected UG-KO mice (see Histological analysis) were incubated with antibodies to either RAGE (1:200), S100A8 (1:50) or S100A9 (1:50), incubated overnight at 4°C in PBS, pH 7.6, containing 2% BSA. Secondary antibodies were: goat anti-rabbit-alexafluor488 (for RAGE, Fig. 3B ), goat anti-rabbitalexafluor594 (for RAGE, Fig. 4A and 4B), antigoat-alexafluor488 (for S100A8 or S100A9, Fig.  4A , 4B and S2A) or anti-goat-alexafluor594 (for S100A8 or S100A9, Fig. 3C and 3D) conjugated secondary antibodies (Invitrogen) in PBS, pH 7.6, containing 2% BSA at room temperature for 1 h. Nuclei were stained with 4,6-diamidino-2-phenylindole dihydrochloride (DAPI, Sigma). For the detection of MMPs in the tumor infiltrated lungs, sections of the lung tissues were pre-heated in citric acid buffer using microwave as described previously (34) . Briefly, the slides were placed in a plastic jar containing 500 ml of 0.1 M sodium citrate buffer with pH 6.0. The slides were heated in the microwave oven (Haier) for four 5-min cycles at 800 W with a break between the cycles to check the buffer levels. After heat treatment the jar was allowed to cool for 30 min. The slices were then washed with distilled water once followed by two washes with PBS, and immunostained as follows. The lung sections were first blocked with 5% BSA for one hour, and then overlaid with anti-MMP-2, anti-MMP-9 and anti-MMP-14 antibodies (1:100) and incubated overnight at 4°C. The slides were washed three times with PBS and further incubated with anti-rabbit-Alexafluor 594 (1:250) for 1 hr. After three washes with PBS, fluorescence was visualized using LSM-510 inverted confocal microscope (Zeiss), and the images were processed with the LSM Image Browser version 4.2 (Zeiss).
Statistical analysis-Statistical analyses of the data were performed by Student's t-test using Excel Office 2000 (Microsoft) and p-values of <0.05 were considered statistically significant.
RESULTS

Elevated levels of metastasis in the lungs
of mice lacking UG-To determine whether UGdeficiency predisposes mice to increased cancer cell metastasis, we injected B16F10 melanoma cells in the dorsal tail vein of the UG-KO mice and their WT littermates (see Experimental Procedures). We then quantitated the number of metastasized tumors in the lungs. We chose B16F10 cells because these cells are known to be preferentially invasive to the lungs (6, 9). Our results show that while there were only a few small tumors detectable in the lungs of the WT mice (Fig. 1A, left panel) , numerous medium to large size tumor colonies were detectable in those of the UG-KO littermates (Fig. 1A, middle  panel) . The quantitation of the tumors in the lungs confirmed that metastasis of B16F10 cells occurred in the lungs of the UG-KO mice at a much higher level compared with that of their WT littermates (Fig. 1A, right panel) . Histological analysis showed infrequent small colonies of tumors in the parenchyma of the lungs from WT mice (Fig. 1B, upper panel) , while medium to large B16F10 tumors were readily found in those of the UG-KO littermates (Fig. 1B, lower panel) .
UG-KO mouse lungs contain soluble chemoattractants for B16F10 cells-To determine
whether the lungs of the UG-KO mice contain soluble factor(s) that promotes homing of B16F10 cells to the lungs, we performed in vitro migration assays (Fig. 1C) . In these experiments, we used conditioned media generated by culturing slices of lung tissues from either UG-KO mice or their WT littermates and used these media as chemoattractants (see Methods). Non-conditioned medium was used as control. The results show that while non-conditioned medium failed to stimulate chemotactic migration (Fig. 1D, subpanel 1) , the conditioned medium generated by culturing WT lung slices only slightly stimulated the migration of B16F10 cells from the upper to the lower chamber (Fig. 1D, sub-panel 2) . However, the conditioned media obtained from culturing lung slices from UG-KO mice dramatically stimulated the migration of these tumor cells (Fig. 1D, sub-panel 3) . These results were further confirmed by quantitation of the cells that completed migration across the filter separating the upper chamber from the lower chamber (Fig. 1D, sub-panel 4) suggesting that the conditioned media from the UG-KO mouse lung cultures contain potent chemoattractant(s) that stimulates the migration of the B16F10 cells in vitro.
UG-KO mouse lungs express high levels of S100A8 and S100A9-We previously reported that UG-KO mice are susceptible to pulmonary inflammation (17) and recently, it has been demonstrated that RAGE (receptor for advanced glycation end products) and its ligands may constitute a new pathway for pulmonary inflammation (35) . The S100 protein family, especially S100A8 (29) and S100A9 (27) , are cytoplasmic EF-hand Ca 2+ -binding proteins (36) , which are some of the ligands that have been linked to human inflammatory and neoplastic diseases (37) . Thus, we sought to determine the levels of expression of S100 proteins and RAGE in the lungs of UG-KO mice. Accordingly, using total RNA from the lung tissues of UG-KO mice and their WT littermates, we first determined the mRNA levels of several S100 genes that are associated with inflammation. The results showed that among six S100 genes surveyed (Supplemental Fig. S1 ), the mRNA levels of only two genes, S100A8 and S100A9, were significantly higher in the lungs of the UG-KO mice compared with those of the WT littermates ( Fig. 2A) . Consistent with these results, the S100A8/S100A9-protein levels were also higher in the lungs of the UG-KO mice (Fig. 2B) . We also performed immunohistochemical analysis to determine which cell type(s) in the UG-KO lungs produced S100A8 and S100A9. The results showed that the lung parenchymal cells are immunopositive for these proteins (Supplemental Fig. S2A) . Moreover, we found that the serum levels of these proteins in the UG-KO mice are also elevated (Fig. 2C) . Interestingly, although the expression level of RAGE-mRNA was slightly higher in the lungs of the UG-KO mice (Supplemental Fig. S2B ), a clear difference in RAGE-protein levels between the WT and UG-KO lungs were not readily discernable (Supplemental Fig. S2C ).
B16F10 cells express RAGE but not S100A8 and S100A9-Since RAGE acts as receptor for S100A8 and S100A9 proteins, we sought to determine whether B16F10 cells express both of these ligands and RAGE. Accordingly, we determined the mRNA and protein levels of S100A8/S100A9 as well as their receptor, RAGE, in B16F10 cells. The results show that while the expression of RAGE-mRNA (Fig. 3A, left panel) and RAGE-protein (Fig. 3A, middle panel) are readily detectable in B16F10 cells, the expression of S100A8 and S100A9 was undetectable (Fig. 3A,  right panel) . Consistent with these results, RAGE immunofluoresce analysis also showed high level of expression of this S100-receptor on B16F10 cells (Fig. 3B) . Remarkably, the expression of S100A8 and S100A9 in B16F10 cells was virtually undetectable (Fig. 3C and 3D) . We then determined RAGE expression in metastasized B16F10 cells in UG-KO lungs by immunofluorescence. The results show high levels of RAGE-specific immunofluorescence colocalizing with S100A8 and S100A9 over the tumors (Fig. 4) . Taken together, these results demonstrate that while the lung tissues of the UG-KO mice express high levels of S100A8/S100A9, the B16F10 cells express their binding partner, RAGE, at an elevated level. This raises the possibility that circulating S100A8/S100A9 provides the homing signal for the RAGEexpressing B16F10 cells to the UG-KO mouse lungs, which contains the highest levels of these proteins.
Chemotactic migration of B16F10 cells mediated by S100A8/S100A9 requires RAGE-To
determine whether S100A8 and S100A9 in the lungs of the UG-KO mice are indeed the chemoattractants for RAGE-positive B16F10 cells, we performed in vitro migration assays using medium containing either recombinant S100A8 or S100A9 or a combination of the two proteins. Medium without these proteins served as control. Our results show that compared with the control, both S100A8-and S100A9-containing media stimulated significantly higher levels of migration of the B16F10 cells and the combination of both proteins appears to have a mild additive effect (Fig.  5A, upper panels) . We then sought to delineate the role of RAGE in S100A8/S100A9-mediated chemotactic migration of B16F10 cells. Accordingly, we pretreated the B16F10 cells with a blocking antibody to RAGE and performed the chemotactic migration assays using media containing recombinant S100A8, S100A9 or a combination of the two proteins. The results showed that while the B16F10 cells migrated towards the media containing recombinant S100A8 or S100A9, such migration was markedly inhibited when the cells were pre-treated with blocking antibody to RAGE (Fig. 5A, middle  panels) . Notably, pre-treatment of the cells with a non-specific IgG did not inhibit S100A8-or S100A9-induced chemotactic migration (Fig. 5A,  lower panels) . The quantitation of the migrated cells confirmed these findings (Fig. 5B) . We also performed in vitro invasion assays using nontransfected, scrambled siRNA-transfected and RAGE siRNA-transfected B16F10 cells using S100A8 and S100A9 as chemoattractants. The results showed that only RAGE-specific siRNA transfection, which inhibited the level of RAGE protein (Supplemental Fig. S3A) , markedly suppressed B16F10 invasion in vitro (Supplemental Fig. S3B) . We then injected the RAGE siRNA-transfected and scrambled siRNAtransfected B16F10 cells in the tail vein of the UG-KO mice to determine whether suppression of RAGE inhibited B16F10 colonization in the lungs. The results showed that only RAGE-specific siRNA-transfection suppressed lung colonization (Supplemental Fig. S3C ). Taken together, these results demonstrate that the migration and invasion of the B16F10 cells in vitro as well as in vivo requires the S100A8/S100A9 and RAGE.
Concentrations of S100A8/S100A9 from the tail vein and in the lungs of UG-KO mice-How
might B16F10 cells, introduced in the tail vein, migrate and colonize the lungs of the UG-KO mice? We entertained the hypothesis that there is a low to high gradient of S100A8 and S100A9 proteins from the tail vein (where the cancer cells are injected) to the UG-KO mouse lungs, which produce the highest levels of S100A8 and S100A9. Accordingly, we obtained blood samples by canulating the tail-as well as the pulmonary-vein and the sera were analyzed S100A8 and S100A9 levels by Western blot analysis. The results showed that the levels of both of these proteins were appreciably lower in the blood samples from the tail vein compared with those in the blood samples obtained from the pulmonary vein (Supplemental Fig. S4) . Interestingly, we found that treatment of B16F10 cells with recombinant S100A8 or S100A9 augments the level of RAGE expression (Supplemental Fig. S5 ). This may indicate that after encountering increasing concentrations of S100A8/A9 these cells elevate the RAGE levels to bind more ligand. Taken together, these results suggested the existence of a low to high S100A8/S100A9 gradient, which most likely provides a roadmap for the RAGE-positive B16F10 cells, injected in the tail vein, to migrate to the lungs, where the concentration of these proteins was the highest.
B16F10 cells acquire invasiveness by expressing MMPs stimulated by S100A8/S100A9-
How might B16F10 cells, upon arrival at the lungs, become acquire invasiveness required for metastasis to the lung parenchyma? It is a general consensus that the extracellular matrices (ECMs) of cancer cells as well as those of the noncancerous cells within the tumors have profound impact on tumor progression and metastasis (38) . Interestingly, matrix metalloproteinases (MMPs), a family of proteolytic enzymes (especially MMP-2, MMP-9 and MMP-14), have been shown to regulate the nature of the tumor microenvironment and increased expression as well as activation of these enzymes are found in virtually all metastasizing human cancers (39) (40) (41) . Thus, we sought to determine whether RAGE-positive B16F10 cells, upon encountering high levels of S100A8/S100A9 in the UG-KO mouse lungs, overexpress MMPs that confer invasiveness on these cells, essential for metastasis. Accordingly, we treated B16F10 cells with recombinant S100A8 or S100A9 and determined the expression of mRNAs for MMP-2, MMP-9 and MMP-14 by real time RT-PCR. The results showed elevated mRNA levels for all three MMPs in B16F10 cells treated with S100A8 or S100A9 (Supplemental Fig. S6 ). Since it has been reported that the S100A8 and S100A9 heterodimerize to yield maximum stimulation of gene expression, we treated B16F10 cells with a combination of recombinant S100A8 (1µg/ml) and S100A9 (1µg/ml) and determined the mRNA and protein levels of MMP-2, MMP-9 and MMP-14. We chose to study these three MMPs as it has been previously reported that these proteinases confer invasiveness to tumor cells promoting metastasis (42, 43) . The results of real time RT-PCR revealed that the mRNA levels of MMP-2, MMP-9 and MMP-14 in B16F10 cells treated with a combination of S100A8 and S100A9 were markedly elevated (Fig. 6A) . To determine whether these MMPs are enzymatically active, we analyzed the levels of mature (active) MMP-2, MMP-9 and MMP-14 by Western blot analysis of homogenates of untreated and S100A8/S100A9-treated B16F10 cells. The results showed elevated levels of mature MMP2, MMP-9 and MMP-14 proteins in S100A8/S100A9-treated B16F10 cells (Fig. 6B) . Interestingly, treatment of B16F10 cells with S100A8/S100A9 also stimulated the expression of furin (Fig. 6A and 6B) , a proprotein convertase that regulates the enzymatic activity of some MMPs such as MMP-14 (MT1-MMP) (44) . Thus, it is likely that furin activated MMP-14, which in turn activated MMP-2. This notion is supported by the demonstration that heterodimerization of activated MMP-14 with MMP-2 activates MMP-2 (44) . The mechanism of activation of MMP-9 remains unclear. To determine whether B16F10 cells after arriving at the S100A8-/S100A9-laden lungs of UG-KO mice produce MMPs in vivo we conducted immunofluorescence studies using antibodies against MMP-2, MMP-9 and MMP-14. The results showed that all three MMPs were expressed by the metastasized B16F10 tumors in the UG-KO lungs at a high level (Fig. 6C) . Taken together, our results suggest that S100A8 and S100A9 not only stimulate the expression of MMPs associated with cancer metastasis but also increases the levels of mature (active)-MMP-2, MMP-9 as well as MMP-14 in B16F10 cells, essential for metastasis of these cancer cells to the UG-KO mouse lungs.
DISCUSSION
Cancer metastasis is a multistep process, which requires coordinated actions of several genes (6-9, 45, 46). We previously reported that the lungs of the UG-KO mice express genes that are known to mediate inflammation (17) . In the present study, we found that the expression of several other genes related to inflammation (e.g. CARMA1, Maspin, RANK and TNFα) is also appreciably elevated in the UG-KO mouse lungs (Supplementary Fig. S7) . Thus, the lack of UG in the lungs of these mice creates a pro-inflammatory microenvironment conducive for B16F10 cell invasion and metastasis. Indeed, consistent with our findings, recent evidence indicates a critical role of tumor microenvironment on cancer development and metastasis (11, 12, 33, 47) . Moreover, it has been shown that primary tumors secrete soluble factors such as TGFß and TNFα that stimulate the production of proteins, S100A8 and S100A9, in epithelial and myeloid cells within the lung prior to tumor metastasis (32, 48) . Thus, it is possible that S100A8/S100A9-mediated inflammatory response in the UG-KO mouse lungs provides a microenvironment conducive for B16F10 cells to anchor, invade and establish metastasis.
The results of our experiments identify three important parameters that coordinately link inflammatory microenvironment in UG-KO mouse lungs with the progression of metastasis of B16F10 cells. These are: (i) UG-deficiency causing elevated level of expression of S100A8/S100A9 proteins in the lungs; (ii) presence of RAGE on B16F10 cells and the existence of a circulating S100A8/S100A9 gradient in the UG-KO mice, which serves as a homing signal for the cancer cells to arrive at the destination (lungs), which contains the highest level of these proteins and (iii) elevated expression as well as activation of MMP-2, MMP-9 and MMP-14 in B16F10 cells in response to S100A8/S100A9. Most importantly, the suppression of S100A8/S100A9-mediated chemotactic migration of B16F10 cells by a blocking antibody to RAGE identifies RAGE as a potential drug target
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Fig. 2:
Expression of S100A8 and S100A9 in WT and UG-KO mice and expression of RAGE in B16F10 cells. S100A8 and S100A9-mRNA levels are dramatically elevated in the lungs of UG-KO mice compared with those of the WT littermates (A). The S100A8-and S100A9-protein levels were also significantly higher in the lung tissues (B) as well as in the serum (C) of the UG-KO mice compared with those of the WT littermates.
Fig. 3:
Expression of RAGE as well as S100A8 and S100A9 in B16F10 cells. (A, left panel) Products obtained from RT-PCR using B16F10 cDNA and primers specific for RAGE, S100A8 or S100A9 were run on an agarose gel to show the presence of RAGE-mRNA and absence of any detectable amounts of S100A8 or S100A9 in B16F10 cells. (A, middle panel) Western blot analysis of B16F10 cell lysates using RAGE-antibody confirmed RAGE-production in these cells. (A, right panel) Western blot analysis of B16F10 cell lysates with S100A8 or S100A9 antibodies failed to show either S100A8-or S100A9-protein bands. UG-KO mice lung lysate was used as the positive control for S100A8/S100A9. (B) Immunocytochemistry of B16F10 cells with the antibody against RAGE clearly showed the presence of RAGE (green) in the B16F10 cells. Immunocytochemical analysis of B16F10 cells using RAGE (green) and S100A8 (red) or RAGE (green) and S100A9 (red) antibodies showed B16F10 cells are positive for RAGE but do not produce S100A8 (C) and S100A9 (D). DAPI (blue) was used to stain the nuclei.
Fig. 4:
Co-localization of RAGE and S100A8/A9 on the B16F10 tumors in UG-KO lungs. Confocal microscopy of lung tissues from UG-KO mice injected with B16F10 cells using antibodies against RAGE as well as S100A8 and S100A9 showing that RAGE (red) colocalized with both S100A8 (panel A, green) and S100A9 (panel B, green). DAPI (blue) was used to stain the nuclei. Tumors are outlined with dotted lines.
Fig. 5:
Suppression of chemotactic migration of B16F10 cells by blocking antibody to RAGE. B16F10 cells were pre-incubated with a blocking goat antibody to RAGE or with a non-specific goat IgG for one hour prior to performing the in vitro migration assay using media containing either S100A8 or S100A9 or a combination of S100A8 and S100A9 as chemoattractants. Medium containing no chemoatractants served as control. The results showed that treatment of the cells with the blocking antibody to RAGE significantly suppressed the migration of the B16F10 cells. Representative photo-micrographs for each treatment are shown in (A). These results were further confirmed by quantitation of the migrating cells under the microscope (B). 100μm 100μm S100A8 S100A9 S100A8+S100A9 None S100A8 S100A9 S100A8+S100A9 None S100A8 S100A9 S100A8+S100A9 None 
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